Page last updated: 2024-11-04

sulforaphane and Bone Loss, Osteoclastic

sulforaphane has been researched along with Bone Loss, Osteoclastic in 2 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Louka, P1
Orriss, IR1
Pitsillides, AA1
Thaler, R1
Maurizi, A1
Roschger, P1
Sturmlechner, I1
Khani, F1
Spitzer, S1
Rumpler, M1
Zwerina, J1
Karlic, H1
Dudakovic, A1
Klaushofer, K1
Teti, A1
Rucci, N1
Varga, F1
van Wijnen, AJ1

Other Studies

2 other studies available for sulforaphane and Bone Loss, Osteoclastic

ArticleYear
High bone mass in mice can be linked to lower osteoclast formation, resorptive capacity, and restricted in vitro sensitivity to inhibition by stable sulforaphane.
    Cell biochemistry and function, 2022, Volume: 40, Issue:7

    Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Isothiocyanates; Ligands; Macrophag

2022
Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
    The Journal of biological chemistry, 2016, Mar-25, Volume: 291, Issue:13

    Topics: Activating Transcription Factor 4; Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorp

2016